BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 15753396)

  • 1. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
    Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
    Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
    Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells.
    García-Morales P; Hernando E; Carrasco-García E; Menéndez-Gutierrez MP; Saceda M; Martínez-Lacaci I
    Mol Cancer Ther; 2006 Sep; 5(9):2172-81. PubMed ID: 16985050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.
    Bai J; Nakamura H; Ueda S; Kwon YW; Tanaka T; Ban S; Yodoi J
    J Biol Chem; 2004 Sep; 279(37):38710-4. PubMed ID: 15247282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer activity of protocatechualdehyde in human breast cancer cells.
    Choi J; Jiang X; Jeong JB; Lee SH
    J Med Food; 2014 Aug; 17(8):842-8. PubMed ID: 24712725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β.
    Choi CH; Lee BH; Ahn SG; Oh SH
    Biochem Biophys Res Commun; 2012 Feb; 418(4):759-64. PubMed ID: 22310719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
    Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW
    BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells.
    Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Choi J
    PLoS One; 2013; 8(4):e60383. PubMed ID: 23565238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
    Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
    Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth.
    Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
    Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end-product-inhibited cell proliferation and protein expression of beta-catenin and cyclin D1 are dependent on glycogen synthase kinase 3beta in LLC-PK1 cells.
    Lin KH; Guh JY; Mo JF; Chiou SJ; Hwang CC; Chuang LY
    Arch Biochem Biophys; 2008 Sep; 477(1):27-32. PubMed ID: 18474214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
    Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
    Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
    Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
    Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of glycogen synthase kinase 3β overexpression in rat and glycogen synthase kinase 3β inhibitor SB-216763 on proliferation of hepatic oval cells].
    Zhong JQ; Xie YK; Ji XK; Fu JH; Wang Y; Zhang QY; Shi HQ; Shan YF
    Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):1003-6. PubMed ID: 23302485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest.
    Luo H; Zhang J; Dastvan F; Yanagawa B; Reidy MA; Zhang HM; Yang D; Wilson JE; McManus BM
    J Virol; 2003 Jan; 77(1):1-9. PubMed ID: 12477805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability.
    Hashemolhosseini S; Nagamine Y; Morley SJ; Desrivières S; Mercep L; Ferrari S
    J Biol Chem; 1998 Jun; 273(23):14424-9. PubMed ID: 9603954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase 3beta induces cell cycle arrest in a cyclin D1-dependent manner in human lung adenocarcinoma cell line A549.
    Li JS; Zhu M; Tian D; Wang MX; Wang F; Li NP; Wu RL
    Sheng Li Xue Bao; 2007 Apr; 59(2):204-9. PubMed ID: 17437044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
    Ghosh JC; Altieri DC
    Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
    Ong CS; Zhou J; Ong CN; Shen HM
    Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.